These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1907076)
1. Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. Wronski TJ; Yen CF; Scott KS J Bone Miner Res; 1991 Apr; 6(4):387-94. PubMed ID: 1907076 [TBL] [Abstract][Full Text] [Related]
2. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Wronski TJ; Dann LM; Scott KS; Crooke LR Endocrinology; 1989 Aug; 125(2):810-6. PubMed ID: 2502377 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats. Lepola VT; Kippo K; Hannuniemi R; Laurén L; Virtamo T; Osterman T; Jalovaara P; Sellman R; Väänänen HK J Bone Miner Res; 1996 Oct; 11(10):1508-17. PubMed ID: 8889851 [TBL] [Abstract][Full Text] [Related]
4. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Wronski TJ; Dann LM; Qi H; Yen CF Calcif Tissue Int; 1993 Sep; 53(3):210-6. PubMed ID: 8242475 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats. Li M; Shen Y; Qi H; Wronski TJ Anat Rec; 1996 Jul; 245(3):472-80. PubMed ID: 8800405 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Wronski TJ; Yen CF; Qi H; Dann LM Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497 [TBL] [Abstract][Full Text] [Related]
7. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Wronski TJ; Cintrón M; Doherty AL; Dann LM Endocrinology; 1988 Aug; 123(2):681-6. PubMed ID: 3396505 [TBL] [Abstract][Full Text] [Related]
8. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia. Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415 [TBL] [Abstract][Full Text] [Related]
9. Lack of an effect of sodium zeolite A on rat tibia histomorphometry. Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption. Turner RT; Evans GL; Wakley GK J Bone Miner Res; 1993 Mar; 8(3):359-66. PubMed ID: 8456590 [TBL] [Abstract][Full Text] [Related]
11. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats. Bowman AR; Sass DA; Marshall I; Ma YF; Liang H; Jee WS; Epstein S J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256 [TBL] [Abstract][Full Text] [Related]
12. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats. Erben RG; Bromm S; Stangassinger M Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. Qi H; Li M; Wronski TJ J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319 [TBL] [Abstract][Full Text] [Related]
14. Effect of fluoride on bone and bone cells in ovariectomized rats. Modrowski D; Miravet L; Feuga M; Bannié F; Marie PJ J Bone Miner Res; 1992 Aug; 7(8):961-9. PubMed ID: 1442210 [TBL] [Abstract][Full Text] [Related]
15. Preventive effects of ginsenosides on osteopenia of rats induced by ovariectomy. Cui L; Wu T; Li QN; Lin LS; Liang NC Acta Pharmacol Sin; 2001 May; 22(5):428-34. PubMed ID: 11743891 [TBL] [Abstract][Full Text] [Related]
16. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Liang H; Pun S; Wronski TJ Endocrinology; 1999 Dec; 140(12):5780-8. PubMed ID: 10579344 [TBL] [Abstract][Full Text] [Related]
17. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats. Shen Y; Li M; Wronski TJ Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164 [TBL] [Abstract][Full Text] [Related]
18. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats. Sato M; Bryant HU; Iversen P; Helterbrand J; Smietana F; Bemis K; Higgs R; Turner CH; Owan I; Takano Y; Burr DB J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007 [TBL] [Abstract][Full Text] [Related]
19. Alfacalcidol restores cancellous bone in ovariectomized rats. Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364 [TBL] [Abstract][Full Text] [Related]
20. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure. Tang LY; Jee WS; Ke HZ; Kimmel DB J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]